INVO Bioscience Price on December 4, 2024
INVODelisted Stock | USD 0.84 0.03 3.45% |
If you're considering investing in INVO Stock, it is important to understand the factors that can impact its price. As of today, the current price of INVO Bioscience stands at 0.84, as last reported on the 9th of December, with the highest price reaching 0.87 and the lowest price hitting 0.80 during the day. INVO Bioscience is out of control given 3 months investment horizon. INVO Bioscience holds Efficiency (Sharpe) Ratio of 0.0808, which attests that the entity had a 0.0808% return per unit of volatility over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.15% are justified by taking the suggested risk. Use INVO Bioscience risk adjusted performance of 0.0343, and Market Risk Adjusted Performance of 0.059 to evaluate company specific risk that cannot be diversified away.
INVO Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
INVO |
Sharpe Ratio = 0.0808
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | INVO | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
14.18 actual daily | 96 96% of assets are less volatile |
Expected Return
1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average INVO Bioscience is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INVO Bioscience by adding it to a well-diversified portfolio.
Related Headline
NLS Pharmaceutics Headline on 4th of December 2024
NLS Pharmaceutics Ltd. Announces Pricing of Private Placemen... by finance.yahoo.com
NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the pricing of a private placement offering consisting of the issuance and sale of up to 322,580 common shares only, par value CHF 0.80 per share, at a purchase price of 3.10 per common share, for aggregate gross proceed
INVO Bioscience Valuation on December 4, 2024
It is possible to determine the worth of INVO Bioscience on a given historical date. On December 4, 2024 INVO was worth 0.87 at the beginning of the trading date compared to the closed value of 0.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of INVO Bioscience stock. Still, in general, we apply an absolute valuation method to find INVO Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of INVO Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against INVO Bioscience's related companies.
Open | High | Low | Close | Volume | |
0.90 | 0.90 | 0.80 | 0.87 | 64,914 | |
11/12/2024 | 0.87 | 0.87 | 0.80 | 0.84 | 29,551 |
0.87 | 0.87 | 0.80 | 0.84 | 0.00 |
Backtest INVO Bioscience | | | INVO Bioscience History | | | INVO Bioscience Valuation | Previous | Next |
INVO Bioscience Trading Date Momentum on December 4, 2024
On December 09 2024 INVO Bioscience was traded for 0.84 at the closing time. The top price for the day was 0.87 and the lowest listed price was 0.80 . There was no trading activity during the period 0.0. Lack of trading volume on December 9, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.57% . |
INVO Bioscience Fundamentals Correlations and Trends
By evaluating INVO Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among INVO Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. INVO financial account trend analysis is a perfect complement when working with valuation or volatility modules.About INVO Bioscience Stock history
INVO Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for INVO is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in INVO Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing INVO Bioscience stock prices may prove useful in developing a viable investing in INVO Bioscience
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. The company was founded in 2007 and is based in Sarasota, Florida. Invo Bioscience operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
INVO Bioscience Stock Technical Analysis
INVO Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
INVO Bioscience Period Price Range
Low | December 9, 2024
| High |
0.00 | 0.00 |
INVO Bioscience cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
INVO Bioscience December 9, 2024 Market Strength
Market strength indicators help investors to evaluate how INVO Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INVO Bioscience shares will generate the highest return on investment. By undertsting and applying INVO Bioscience stock market strength indicators, traders can identify INVO Bioscience entry and exit signals to maximize returns
INVO Bioscience Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for INVO Bioscience's price direction in advance. Along with the technical and fundamental analysis of INVO Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of INVO to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0343 | |||
Jensen Alpha | (0.66) | |||
Total Risk Alpha | (1.74) | |||
Sortino Ratio | 0.0503 | |||
Treynor Ratio | 0.049 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |